Two Problems That Vanish with the End of Cannabis Prohibition
Jul 18, 2024
auto_awesome
Paul Best, an expert in cannabis policy, discusses the banking challenges faced by marijuana businesses due to federal prohibition. Ending prohibition could ease banking issues and enable more research on cannabis.
Cannabis businesses face banking challenges due to federal prohibition, leading to cash-only operations and security risks.
Federal prohibition inhibits cannabis research, hindering exploration of therapeutic benefits and necessitating broader scientific investigations.
Deep dives
Challenges of Banking Services for Cannabis Retailers
Cannabis businesses face obstacles in accessing standard banking services due to federal cannabis prohibition laws that deter banks from engaging with them. As a result, many legal cannabis retailers are compelled to operate on a cash-only basis, leading to security risks, increased operational costs, and vulnerabilities to criminal activities such as robberies. FinCEN's stringent regulations further hinder financial institutions from providing comprehensive services, contributing to the banking challenges impacting the industry.
Research Restrictions and the Prominence of Federal Regulations
Despite the legalization of cannabis in numerous states, federal cannabis prohibition restricts research efforts on the plant's therapeutic and adverse effects. The classification of cannabis as a Schedule I drug impedes scientific exploration, creating barriers for researchers to delve into its potential benefits and drawbacks fully. While a potential reclassification to Schedule III may acknowledge some medical applications, it falls short of eliminating the need for broader research opportunities and comprehensive reforms to facilitate scientific investigations into cannabis.
Most Americans have access to either medical or recreational cannabis, but prohibition at the federal level persists, and that prohibition keeps in place at least two big problems. Paul Best explains.